NIH, NINR, and AHRQ Funding Opportunity Announcements
| Dates and Deadlines | Title | Summary Information |
|---|---|---|
|
Application Due Date: November 1, 2023 5pm local time (both ROAs)
|
OTA-23-007 HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2) OTA-23-008 HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain Native Research Resource Network (OT2) |
ROA OTA-23-007 solicits applications from Tribes and Native American Serving Organizations (T/NASOs) for the planning, development, piloting, and/or implementation of research and/or data improvement projects. T/NASOs are defined as federally or state recognized Tribes and organizations with a core mission to serve and/or a track record in serving Native Americans and that are poised to reach this population ROA OTA-23-008 solicits applications from T/NASOs and Ally Organizations to form a Native Research Resource Network. Ally Organizations are defined as organizations with a demonstrated track record of partnering successfully with Native American communities. The network will provide comprehensive training and resources to support T/NASOs in real time as they lead research and data improvement projects. Components of the network will also provide coordination of resources, reporting, and cross-site activities. For more information, please visit N CREW Program website |
|
Expiration Date: Oct. 01, 2025 |
NOT-OD-23-031: This is a reissuance of NOT-OD-20-054. The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning from mentored career development awards to research independence and to minimize departures from biomedical research workforce. This supplement program is intended to ensure continuity of research among recipients of mentored career development (K) awards by providing supplemental research support to help sustain the investigator’s research during a period in which the PD/PI experiences critical life events which have the potential to impact research progress or potential productivity. Administrative supplements must support work within the scope of the original project. NOT-OD-23-032: This is a reissuance of NOT-OD-20-055. The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diverse talent in the biomedical research workforce. This program supports “at-risk” investigators as identified in the NIH Next Generation Researchers Initiative (see https://grants.nih.gov/ngri.htm). |
|
|
Remaining Application Due Dates: Oct. 10, 2023, and Feb. 13, 2024 Expires: Feb. 14, 2024 |
This Funding Opportunity Announcement (FOA) will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings with adequate sample size. These trials are intended to produce results that can be directly adopted by healthcare providers, patients, or caregivers for rapid dissemination and implementation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care across multiple settings; and/or (4) reduce disparities in dementia care. This FOA will support Stage I or Stage III pilot research to test the feasibility of implementing and integrating interventions (R61 phase) that, if successful, can transition to an R33 phase (Stage IV) for implementation of large pragmatic trials. The transition from the R61 to the R33 phase of the award will be administratively reviewed and determined by successful completion of the go/no-go criteria that are specified for the R61 phase. |
|
|
Remaining Application Due Dates: Oct. 10, 2023, and Feb. 13, 2024 Expires: Feb. 14, 2024 |
PAR-21-307: Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) |
This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) and of those providing their care. The NIH Stage Model offers a framework to: (1) support development of efficacious interventions that are defined by their principles; and (2) ensure that these efficacious interventions can be administered in the community or in health systems with fidelity to the intervention’s principles. This includes the development, testing, and validation of scalable training materials and procedures so that these interventions can be delivered with fidelity in community settings or health systems. Settings can include the home, community, or formal care settings, such as nursing homes, assisted living facilities, nursing and rehabilitation centers, hospitals, adult day care, and specialized hospice settings. The overarching purpose of this FOA is to help to lay the groundwork for real-world implementation of AD/ADRD care and caregiving interventions. The principle-based interventions under development may target behavioral, psychological, interpersonal, social, or institutional processes and may be designed for use at the individual, family, dyad, group, community, or health-systems level. Applications may propose mechanism-focused intervention research for individuals living with dementia or for individuals or systems providing care for people at any stage of AD/ADRD. Applications proposing the development of interventions that address the principles underlying the care needs and challenges for individuals from diverse racial, ethnic, and socioeconomic backgrounds are strongly encouraged. Applications that involve interdisciplinary expertise and translational expertise (e.g., basic behavioral, social, psychological, or neurobiological science expertise relevant to hypothesized intervention mechanisms; expertise in the AD/ADRD service delivery system; and clinical psychological science expertise in areas outside of aging or AD/ADRD, but potentially relevant to AD/ADRD caregiver research, etc.) are also strongly encouraged. Applications may propose to create, modify, and test AD/ADRD care and caregiver support interventions based upon hypothesized mechanisms of action and are encouraged to incorporate a test of essential components or mechanisms of change using an appropriate methodological approach. |
Other Funding and Training Opportunities
| Dates and Deadlines | Title | Summary Information |
|---|---|---|
| Applications due no later than August 1, 2023 (with rolling acceptances) for earliest possible start date in January 2024. | University of Colorado Palliative Care and Aging Research Training (T32) |
Funded by a Ruth Kirschstein National Research Service Award NRSA T32 from the National Institute on Aging (NIA), this Program builds on the significant Palliative Care expertise and research opportunities within the University of Colorado. Participants become members of the community of scholars at the University of Colorado and are provided with the full array of resources available within the Department of Medicine and the Colorado Clinical & Translational Sciences Institute (CCTSI). More information about T32 opportunities at the University of Colorado Palliative Care Post-Doctoral |
|
Application Due Date: February 1 of desired start year Candidates will be selected on a rolling basis each year until each of the 2 new slots per year are filled. |
Weill Cornell Medicine Post-Doctoral Training Program in Behavioral Geriatrics (T32) |
This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral trainees (2/year) seeking careers at the intersection of biomedical and innovative social/behavioral approaches to improve care and care outcomes in older adults. Please see the links below for more information: |
| Application Due Date: December 15 for funding to start the following year (flexible start dates) |
Fellowships will be 1-3 years in duration. Trainees must have an interest in palliative care research related to heart, lung, or blood disease. Funded by a T32 training grant award from NHLBI. For more details and information about the Palliative Care Research Fellowship, please visit: http://www.uwpalliativecarecenter.com |